Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus

• Published in: Disease markers Vol. 27; no. 6; pp. 269 - 278
• Main Authors: Swellam, Menha, Sayed Mahmoud And, Magda, Abdel-Fatah Ali, Adel
• Format: Journal Article
• Language: English
• Published: IOS Press 01.01.2009
• Subjects: Other
• ISSN: 0278-0240; 1875-8630
• DOI: 10.3233/DMA-2009-0672

OBJECTIVESTo study the interrelationships of adiponectin, C-reactive protein (CRP) and fibrinogen with each other in T2DM patients with (T2DM-C) and without complications (T2DM-NC) among healthy individuals. DESIGN AND METHODSThe study comprised of 120 T2DM-C, 59 T2DM-NC patients and 40 healthy volunteers. Biochemical markers were determined in the serum. RESULTSPositivity rates of CRP and fibrinogen were significantly increased in T2DM-C as compared to T2DM-NC or controls, whereas adiponectin showed highest level in healthy individuals. Inflammatory biomarkers were inversely correlated with adiponectin (P< 0.01). Lipid profiles, kidney functions and BMI, showed positive significant correlation with CRP and fibrinogen but negative correlation with adiponectin. For better detection of T2DM, the combined sensitivity (98.9%) and specificity (92.5%) of fibrinogen and adiponectin was higher than the combined sensitivity and specificity of fibrinogen and CRP or adiponectin and CRP or than that of the biomarkers alone. CONCLUSIONElevated levels of CRP and fibrinogen and reduced level of adiponectin can be used for early diagnosis of T2DM and can predict diabetic complications.